Home › Funds › Royce & Associates › AVDL
Royce & Associates position in AVDL
AVADEL PHARMACEUTICALS PLC
Latest position (Q1 2025)35.46K sh
Reported value held$277.65K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 35.46K | $498.57K | New |
| Q3 2024 | 35.46K | $465.06K | Hold |
| Q4 2024 | 35.46K | $372.69K | Hold |
| Q1 2025 | 35.46K | $277.65K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.